Basics Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients. IPO Date: February 22, 2000 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $407.32M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.89% Avg Daily Range (30 D): $0.02 | 3.20% Avg Daily Range (90 D): $0.04 | 4.65% Institutional Daily Volume Avg Daily Volume: 5.3M Avg Daily Volume (30 D): 4.91M Avg Daily Volume (90 D): 6.59M Trade Size Avg Trade Size (Sh.): 452 Avg Trade Size (Sh.) (30 D): 572 Avg Trade Size (Sh.) (90 D): 611 Institutional Trades Total Inst.Trades: 444 Avg Inst. Trade: $2.06M Avg Inst. Trade (30 D): $2.32M Avg Inst. Trade (90 D): $3.34M Avg Inst. Trade Volume: 1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.45M Avg Closing Trade (30 D): $2.32M Avg Closing Trade (90 D): $3.91M Avg Closing Volume: 1.78M         News May 21, 2025 @ 9:06 PM Senseonics Holdings, Inc. Announces Closing of Pub... Source: N/A May 21, 2025 @ 5:47 PM Diabetic Care Device Market Set for Significant Gr... Source: Bcc Research Jan 8, 2025 @ 11:12 PM Senseonics Holdings, Inc. Announces Business Updat... Source: N/A Sep 17, 2024 @ 11:00 AM Eversense 365 Receives FDA Clearance: The Worldââ... Source: Senseonics Holdings, Inc. And Ascensia Diabetes Care Jul 23, 2024 @ 5:31 PM [Latest] US Diabetes Devices Market Size/Share Wor... Source: Custom Market Insights Financials   TTM Q4 2024 FY 2024 Basic EPS $-.02 $-.02 $-.12 Diluted EPS $-.02 $-.02 $-.12 Revenue $ 6.26M $ 8.3M $ 22.47M Gross Profit $ 1.51M $ 3.95M $ .53M Net Income / Loss $ -14.26M $ -15.48M $ -78.62M Operating Income / Loss $ -13.49M $ -14.27M $ -74.84M Cost of Revenue $ 4.75M $ 4.35M $ 21.94M Net Cash Flow $ -35.29M $ 47.49M $ -.8M PE Ratio     Splits Nov 10, 2015:   12:1